SiriusPoint Ltd. (NYSE:SPNT - Free Report) - Research analysts at DOWLING & PARTN issued their FY2028 earnings per share estimates for shares of SiriusPoint in a report issued on Friday, August 7th. DOWLING & PARTN analyst A. Mottolese forecasts that the company will post earnings per share of $3.00 for the year. The consensus estimate for SiriusPoint's current full-year earnings is $2.57 per share.
SiriusPoint (NYSE:SPNT - Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $0.67 EPS for the quarter, topping analysts' consensus estimates of $0.65 by $0.02. The company had revenue of $744.10 million for the quarter, compared to analysts' expectations of $798.95 million. SiriusPoint had a return on equity of 15.65% and a net margin of 15.56%.
A number of other research analysts have also recently weighed in on SPNT. Zacks Research cut shares of SiriusPoint from a "strong-buy" rating to a "hold" rating in a research note on Monday, May 11th. Wall Street Zen downgraded shares of SiriusPoint from a "buy" rating to a "hold" rating in a research report on Saturday, May 9th. Weiss Ratings restated a "buy (b+)" rating on shares of SiriusPoint in a research note on Friday. Finally, B. Riley Financial assumed coverage on shares of SiriusPoint in a report on Friday, April 17th. They issued a "buy" rating and a $31.00 price target on the stock. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $31.00.
Get Our Latest Report on SPNT
SiriusPoint Price Performance
SPNT opened at $22.64 on Wednesday. SiriusPoint has a fifty-two week low of $17.17 and a fifty-two week high of $26.48. The firm has a 50-day moving average of $23.78 and a 200 day moving average of $22.44. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.58 and a current ratio of 0.58. The firm has a market cap of $2.63 billion, a P/E ratio of 5.52 and a beta of 0.61.
Institutional Investors Weigh In On SiriusPoint
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SPNT. Optima Capital LLC bought a new position in SiriusPoint during the fourth quarter worth about $41,000. EverSource Wealth Advisors LLC increased its stake in shares of SiriusPoint by 187.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,113 shares of the company's stock worth $43,000 after purchasing an additional 1,377 shares in the last quarter. Leonteq Securities AG purchased a new position in shares of SiriusPoint in the fourth quarter worth about $136,000. Torren Management LLC bought a new stake in shares of SiriusPoint in the fourth quarter valued at approximately $143,000. Finally, Inspire Investing LLC bought a new stake in shares of SiriusPoint in the fourth quarter valued at approximately $185,000. 52.79% of the stock is currently owned by institutional investors.
About SiriusPoint
(
Get Free Report)
SiriusPoint Ltd. is a global insurance and reinsurance company headquartered in Bermuda, offering a broad range of property and casualty solutions to clients around the world. The company operates through two core segments: reinsurance, which provides treaty and facultative coverage across property, casualty and specialty lines; and insurance, which underwrites specialty programs, fronting arrangements and other tailored products for commercial and niche markets. This integrated model allows SiriusPoint to leverage shared underwriting expertise and capital efficiency across its product suite.
On the reinsurance side, SiriusPoint’s offerings include coverage for natural catastrophes, casualty losses, political risk and other complex exposures, with both proportional and non-proportional treaty structures.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider SiriusPoint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SiriusPoint wasn't on the list.
While SiriusPoint currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.